Monica Di Giacomo weighed 320 pounds and no trainer would take her. Now, after 10 years of work, the Miami woman takes the ...

Kathy Bates is clapping back at critics who say her 100-pound weight loss was a result of Ozempic. The 77-year-old “Matlock” ...

Heather Jahn shares her weight loss transformation story. Growing up, I always struggled with my weight. Once I hit puberty, ...

Yes, your rib cage might appear smaller after you lose weight, even though the bone structure underneath hasn’t changed. Weight loss happens when you burn more calories than you consume. Most areas of ...

Every time I visit a new doctor, sometimes even ones I’ve seen before, I play a little game in my head. I call it: “How long until they tell me to lose weight or passive-aggressively ask about my diet ...

In January, I got a body composition analysis that measured my body fat and muscle mass. I wanted to lose body fat and gain a little more muscle by changing my diet and workouts. Getting a second ...

NEW YORK -- Tennis legend Serena Williams spent her life on the court taking -- and making -- incredible shots for more than two decades. Now, she is speaking publicly about shots she has been taking ...

Williams used GLP-1 drugs to lose weight after childbirth Williams' sign-on adds credibility to the company's offering, investor says Williams' husband Alexis Ohanian is Ro investor, serves on board ...

Serena Williams is sharing how she took a swing at weight loss drugs. The tennis legend, 43, explained she "hit a wall" she had never encountered before after having her kids in a campaign video for ...

Serena Williams used GLP-1s to lose weight after having children, the tennis star says in a new ad campaign for online healthcare company Ro that aims to widen the pool of customers for the drugs.

Aug 19 (Reuters) - Viking Therapeutics (VKTX.O), opens new tab said Tuesday its experimental weight-loss pill helped patients lose 12.2% of their body weight in a mid-stage trial, missing Wall ...

Viking Therapeutics Inc. plunged in early trading on Tuesday after its experimental obesity pill disappointed in a mid-stage study, marking another weaker-than-expected result for an oral alternative ...